Back to Search
Start Over
Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.
- Source :
-
PloS one [PLoS One] 2013 Oct 10; Vol. 8 (10), pp. e76508. Date of Electronic Publication: 2013 Oct 10 (Print Publication: 2013). - Publication Year :
- 2013
-
Abstract
- The expression by tumor cells of proteins with aberrant structure, expression or distribution accounts for the development of a humoral immune response. Autoantibodies (aAb) directed against tumor-associated antigens (TAA) may thus be particularly relevant for early detection of cancer. Serological proteome analysis (SERPA) aims to identify such circulating aAb through the immunoblotting of 2D-separated tumor cell proteins with cancer patient serum and the consecutive MS identification of proteins in reactive spots. This method has the advantage to use post-translationally modified proteins as a source of potential TAA. Here, we applied this strategy by using colorectal tumor cells pre-exposed to hypoxia in order to promote the expression of a pattern of TAA more likely to represent in vivo conditions. We used two human HCT116 and HT29 colorectal cancer cell lines exposed for 48 hours to 1% O2. Spots positive after immunoblotting of 2D-separated lysates of hypoxic cells with the sera of tumor-bearing mice, were collected and analysed by MS for protein identification. Among the hypoxia-specific immunogenic proteins, we identified a phosphorylated form of eukaryotic translation elongation factor 2 (phospho-Thr56 eEF2). We confirmed the increased phosphorylation of this protein in hypoxic colorectal tumor cells as well as in mouse tumors. Using a specific immunoassay, we could detect the presence of corresponding anti-phospho-Thr56 eEF2 aAb in the serum of tumor-bearing mice (vs healthy mice). We further documented that the detection of these aAb preceded the detection of a palpable tumor mass in mice and validated the presence of anti-phospho-Thr56 eEF2 aAb in the serum of patients with adenomatous polyps and colorectal carcinoma. In conclusion, this study validates a phosphorylated form of eEF2 as a new TAA and more generally, provides evidence that integrating hypoxia upstream of SERPA offers a more relevant repertoire of TAA able to unmask the presence of circulating aAb.
- Subjects :
- Aged
Amino Acid Sequence
Animals
Antigens, Neoplasm immunology
Autoantibodies immunology
Biomarkers, Tumor blood
Biomarkers, Tumor chemistry
Cell Hypoxia
Cell Proliferation
Colorectal Neoplasms blood
Colorectal Neoplasms metabolism
Colorectal Neoplasms pathology
HCT116 Cells
HT29 Cells
Humans
Immunoassay
Male
Mice
Molecular Sequence Data
Peptide Elongation Factor 2 blood
Peptide Elongation Factor 2 chemistry
Peptide Elongation Factor 2 metabolism
Phosphoproteins blood
Phosphoproteins chemistry
Phosphoproteins metabolism
Phosphorylation
Serologic Tests
Threonine metabolism
Antigens, Neoplasm blood
Autoantibodies blood
Biomarkers, Tumor immunology
Colorectal Neoplasms immunology
Peptide Elongation Factor 2 immunology
Phosphoproteins immunology
Proteomics
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 8
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 24130777
- Full Text :
- https://doi.org/10.1371/journal.pone.0076508